...
【24h】

Total femur replacement: primary procedure for treatment of malignant tumours of the femur.

机译:全股骨置换:治疗股骨恶性肿瘤的主要方法。

获取原文
获取原文并翻译 | 示例

摘要

We present our experience of treating patients with tumours involving the whole femur with excision and total femur endoprostheses over the last 30 years (1975-2005). There were 26 consecutive patients (14 men and 12 women). Average age was 40 years (14-82 years) at the time of surgery and 21 of the patients had primary malignant bone tumours with five having the procedure for metastases. 11 patients were still alive of which nine were free of disease at the time of review at a mean follow-up of 57 months (3-348). The overall patient survival at 10 years was 37%. The survival of patients with a primary localised tumour was 50% at 10 years. Revision of the prostheses was necessary in two patients (at 110 and 274 months) because of recurrent dislocation and aseptic loosening. Amputation was necessary in two patients but long term limb survival was 92% at 10 years. Nine patients alive with no evidence of disease had a mean MSTS functional score of 72%.
机译:我们介绍了过去30年(1975年至2005年)治疗包括切除整个股骨和全部股骨假体在内的肿瘤患者的经验。连续26例患者(男14例,女12例)。手术时的平均年龄为40岁(14-82岁),其中21例患有原发性恶性骨肿瘤,其中5例进行了转移。平均随访57个月,在复查时11例患者还活着,其中9例没有疾病(3-348)。患者10年的总生存率为37%。患有原发性局部肿瘤的患者在10年时的生存率为50%。由于复发性脱位和无菌性松动,两名患者(分别在110和274个月)必须进行假体修复。两名患者需要截肢,但是10年的长期肢体存活率为92%。尚无疾病迹象的9名患者的平均MSTS功能评分为72%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号